期刊文献+

大肠癌合并肠梗阻42例临床治疗体会 被引量:4

Clinical Treatment of Colorectal Cancer Complicated by Bowel Obstruction: Experience with 42 Cases
下载PDF
导出
摘要 目的探讨外科手术治疗大肠癌合并肠梗阻的处理方法和临床疗效。方法选择42例大肠癌合并肠梗阻的患者,对患者的治疗方法和临床疗效进行分析。结果所有患者均行大肠癌规范化手术治疗,均手术成功,术中平均出血量为(172.4±22.2)mL,平均手术时间为(148.5±16.0)min,治疗的总有效率为64.3%,并发症发生率为7.1%,其中1例切口感染、1例并发心血管疾病,随访3个月无一例死亡,且随着时间的推移,不同时间点的血清癌胚抗原(CEA)及糖类抗原(CA19-9)水平逐渐降低(P<0.05)。结论手术治疗大肠癌并发肠梗阻需根据患者的情况选择适合的手术方式以提高治疗的效果、降低并发症,提高患者的生存率。 Objective To investigate the clinical effects of surgical operation on colorectal cancer complicated by bowel obstruction. Methods Treatment methods and clinical efficacies were analyzed in 42 patients with colorectal cancer and bowel obstruction. Results Standardized surgical procedures were successfully completed in all patients. Average intraoperative blood loss and mean operating time were (172.4±22.2)mL and (148.5±16.0)min, respectively. The total effective rate was 64.3%. The carbohydrate antigen CA19-9 gradually decreased over time (P〈0.05).Conclusion Appropriate surgical approach should be selected according to the patient's condition to improve curative efficacies, reduce complications and increase survival in patients with colorectal cancer and bowel obstruction.
出处 《实用临床医学(江西)》 CAS 2014年第1期52-53,56,共3页 Practical Clinical Medicine
关键词 大肠癌 手术 肠梗阻 并发症 colorectal cancer operation bowel obstruction complication
  • 相关文献

参考文献4

二级参考文献43

  • 1王晓东,高泉根,张少雄,丁海山,姚泽明,郑家芝.老年大肠癌手术126例临床分析[J].中国肛肠病杂志,2005,25(4):40-41. 被引量:5
  • 2王玮,王平,陈贤贵,杨羽中,李勇.复发大肠癌诊治分析(附36例报告)[J].浙江临床医学,2006,8(2):126-127. 被引量:2
  • 3朱春平,林岩,陆晓东,刘国建.持续静脉滴入低剂量5-FU联合亚叶酸钙和奥沙利铂治疗晚期结直肠癌疗效观察[J].中华肿瘤防治杂志,2006,13(1):77-77. 被引量:2
  • 4汤钊.现代肿瘤学.上海:上海医科大学出版社,2000,1223~1230.
  • 5Wen-Sy Tsai. Impact of chemotherapy-related prognostic factors on long- term survival in patients with stage III colorectal cancer after curative resection[J]. Int J Clin Oncol. DOI 10. 1007/s10147-011-0370-8.
  • 6Bleiberg H. Oxaliplatin (L-OHP) : a new reality in colorectal cancer [J]. Br J Cancer,1998,77(Suppl 4) : 1 -3.
  • 7Venook A P. Epidermal. growth factor receptor-targeted treatment for advanced colorectal carcinoma [ J ]. Cancer, 2005, 103 ( 2 ) : 2435 - 2446.
  • 8Maria J Lamas. Anti-EGFR therapy in first-line colorectal cancer[ J ].. Expert Rev. Anticancer Ther,2011,11 (10) : 1499 - 1503.
  • 9Georgios V. Koukourakis. Targeted therapy with bevaeizumab ( Avas- tin) for metastatic colorectal cancer[ J]. Clin Transl Onco1,2011,13 : 710 -714.
  • 10Hurwitz HI, Fehrenbacher L, Hainsworth JDet a1(2005 ) Bevacizumab in combination with fluorouracil and leucovorin: an active regimen for first-line metastatic colorectal cancer [ J]. J Clin Oncol, 2010,23: 3502 - 3508.

共引文献18

同被引文献17

引证文献4

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部